We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Tools for Home Dialysis

By HospiMedica staff writers
Posted on 15 Aug 2005
Dialysis patients spend around four hours a day, three times a week, connected to a large machine in a crowded dialysis center. More...
Now, new systems are aiding the growing movement toward daily dialysis in the home, which research suggests may make patients healthier.

A new peritoneal hemodialysis (PHD) system weighs 300 pounds but boasts simplicity. It is designed to require less training time, less set-up time, and less effort to operate, allowing patients to spend less time on dialysis. A touch screen provides step-by-step instructions that lead patients through the process. Many steps, such as system-wide hot water disinfection and preparation of ultrapure dialysate, are performed automatically. An extended-use corporeal circuit is cleaned, disinfected, and tested while still in place, eliminating daily set-up/tear-down.

This PHD system was developed by Aksys, Ltd. (Lincolnshire, IL, USA; www.aksys.com). The company believes that the PHD system addresses the primary drawback of peritoneal dialysis by delivering a substantially greater dose of dialysis in significantly less time. Also, by enabling the use of more frequent, shorter hemodialysis, the system overcomes other limitations such as the risk of peritonitis and patient noncompliance to the regimen.

Another new system, called System One, is from NxStage Medical (Lawrence, MA, USA; www.nxstage.com). It weighs only 70 pounds, is a portable machine, and offers simple user controls.

Both systems have been cleared by the U.S. Food and Drug Administration (FDA) and both are designed to offer better clinical outcomes, lower total treatment costs, and improved quality of life for patients.





Related Links:
Aksys
NxStage Medical

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.